If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
289.40    -4.60 (-1.56%)
Bid:
289.80
Ask:
291.80
Spread: 2.00 (0.69%)
Market Cap: £2.35b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Director/PDMR Shareholding

25 Mar 2021 17:14

RNS Number : 5559T
Rotork PLC
25 March 2021
 

25 March 2021

Rotork plc

 ("Company")

 

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

 

The Company provides notification of the following transactions undertaken outside of a market venue relating to the below named PDMRs and their respective interests in the ordinary shares of nominal value 0.5p each in the capital of the Company ("Shares") (ISIN: GB00BVFNZH21). 

 

The transactions arise from an award made to each of the PDMRs by the Remuneration Committee on the 24 March 2021 of a three-year performance conditioned nil cost option ("NCO") over, or conditional award ("CA") of, certain Shares under the Company's Long Term Incentive Plan ("2021 LTIP Awards" or "Awards").

 

Individual PDMR details are set out in the table below:

 

Name and position of PDMR

Number of Shares¹ and type of award granted on 24 March 2021

 

Kevin Hostetler

Chief Executive

336,951 CA

Jonathan Davis

Group Finance Director

169,899 NCO

Paul Burke

Chief Information Officer

50,555 NCO

Kathy Callaghan

Group HR Director

43,326 NCO

Kiet Huynh

MD - Chemical, Process & Industrial

43,681 NCO

Neil Manning

MD - Oil & Gas

43,626 CA

Vijay Rao

Strategy and Mergers & Acquisitons Director

41,113 CA

Oliver Wiese

MD - Water & Power

40,307 CA

Grant Wood

Operations Director

43,986 NCO

 

¹ The number of shares in relation to which the Awards were made was based off the avergage MMQ share price for the five business days immediately preceding the date of grant (ie 17-19 and 22-23 March 2021 inclusive). When multiplied through, this represents a value level for Messrs. Hostetler and Davis of 200% and 175% of base salary respectively, in line with the Company's current Directors' Remuneration Policy.

 

The 2021 LTIP awards will normally vest on the third anniversary of grant (i.e. on 24 March 2024) subject to continued employment and the Company's achievement against various stretching performance targets measured over the three-year financial period ending 31 December 2023. The performance conditions set by the Remuneration Committee relate to Earnings Per Share, Total Shareholder Return and Economic Profit, with each condition weighted as to one-third of each Award. Further details of the performance conditions and targets, together with the compulsory two-year holding period attaching to any net of tax vested Shares and the Company's Share Ownership Guidelines (both of which apply to the Executive Directors only), are set out in the Directors' Remuneration Report to the Company's 2020 Annual Report which will be available from 31 March 2021 (see www.rotork.com).

 

All Awards are subject to malus and clawback and, with the exception of those made to the Executive Directors, attract an accrued dividend equivalent entitlement arising during the vesting period on any vested Shares, with such entitlements to be settled in the form of additional Shares.

 

The Company can confirm that each of the above named PDMRs have complied with their respective obligation to notify the Financial Conduct Authority of the above transactions as required under MAR.

 

- END -

 

Rotork contact and telephone number for enquiries:

Joy Baldry, Deputy Company Secretary

+44 (0)7789 920457

 

Notes:

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRGDXIGDDGBU
Date   Source Headline
25th Mar 20258:31 amRNSDirector/PDMR Shareholding
12th Mar 202510:49 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNS2024 full year results
11th Mar 20257:00 amRNSShare buyback programme
11th Mar 20257:00 amRNSAcquisition of Noah Actuation
7th Mar 20251:35 pmRNSHolding(s) in Company
3rd Mar 20259:02 amRNSTotal Voting Rights
11th Feb 20254:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20259:45 amRNSTotal Voting Rights
13th Jan 20254:18 pmRNSDirector/PDMR Shareholding
2nd Jan 20259:43 amRNSTotal Voting Rights
16th Dec 20243:34 pmRNSDirector/PDMR Shareholding
11th Dec 20244:40 pmRNSDirector/PDMR Shareholding
9th Dec 20241:20 pmRNSCompletion of Share Buyback Programme
6th Dec 20245:43 pmRNSTransaction in Own Shares
5th Dec 20245:15 pmRNSTransaction in Own Shares
4th Dec 20245:19 pmRNSTransaction in Own Shares
3rd Dec 20245:10 pmRNSTransaction in Own Shares
3rd Dec 202411:50 amRNSBoard Committee and Board Role Changes
2nd Dec 20245:12 pmRNSTransaction in Own Shares
2nd Dec 20249:27 amRNSTotal Voting Rights
29th Nov 20245:38 pmRNSTransaction in Own Shares
28th Nov 20245:20 pmRNSTransaction in Own Shares
27th Nov 20245:40 pmRNSTransaction in Own Shares
26th Nov 20245:25 pmRNSTransaction in Own Shares
25th Nov 20245:14 pmRNSTransaction in Own Shares
22nd Nov 20245:17 pmRNSTransaction in Own Shares
21st Nov 20245:04 pmRNSTransaction in Own Shares
20th Nov 20245:09 pmRNSTransaction in Own Shares
20th Nov 202411:00 amRNSDirectorate Change
20th Nov 20247:00 amRNSTrading Update
19th Nov 20245:07 pmRNSTransaction in Own Shares
18th Nov 20245:21 pmRNSTransaction in Own Shares
15th Nov 20245:11 pmRNSTransaction in Own Shares
14th Nov 20245:15 pmRNSTransaction in Own Shares
13th Nov 20245:16 pmRNSTransaction in Own Shares
12th Nov 20245:33 pmRNSTransaction in Own Shares
12th Nov 202412:44 pmRNSDirector/PDMR Shareholding
11th Nov 20245:08 pmRNSTransaction in Own Shares
8th Nov 20245:22 pmRNSTransaction in Own Shares
7th Nov 20245:12 pmRNSTransaction in Own Shares
7th Nov 202412:21 pmRNSShare Buy-Back Programme
1st Nov 20249:17 amRNSTotal Voting Rights
25th Oct 20245:36 pmRNSTransaction in Own Shares
24th Oct 20245:10 pmRNSTransaction in Own Shares
23rd Oct 20245:07 pmRNSTransaction in Own Shares
22nd Oct 20245:09 pmRNSTransaction in Own Shares
21st Oct 20244:53 pmRNSTransaction in Own Shares
18th Oct 20244:54 pmRNSTransaction in Own Shares
17th Oct 20245:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.